Response to BSE Query dated Feb 1, 2026 reference no. L/SURV/ONL/PV/APJ/2025-26/889
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BSE's Surveillance Department had asked Strides Pharma Science to explain a sharp increase in trading volume of its shares (reference no. L/SURV/ONL/PV/APJ/2025-26/889, dated Feb 1, 2026). The company replied on Feb 2, 2026 stating that it is in compliance with SEBI's listing and disclosure rules, and that all material and price-sensitive information has already been shared with the stock exchanges. Strides further clarified that it is not aware of any undisclosed announcement that could explain the price or volume movement, and that the volume increase appears to be purely market-driven with no company-specific trigger.
This is a routine exchange query, not a regulatory penalty or adverse action. The company's response rules out any hidden negative news, which may reassure investors that there is no undisclosed event behind the unusual volume. However, it does not explain the surge, so the stock could remain volatile until clearer reasons emerge.